Drug Safety and Availability > FDA Drug Safety Communication: Safety review update on the possible increased risk of blood clots with birth control pills containing drospirenone

This update is in follow-up to the FDA Drug Safety Communication posted on 9/26/2011: Safety review update on the possible increased risk of blood clots with birth control pills containing drospirenone.

full-text:
Drug Safety and Availability > FDA Drug Safety Communication: Safety review update on the possible increased risk of blood clots with birth control pills containing drospirenone